1-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine → HCID 66616474、化合物

HRID 1914227

反応式

HRID 1914227 の反応式
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:11]2[C:12]([CH2:19][CH3:20])([CH2:17][CH3:18])[C:13](=[O:16])[NH:14][N:15]=2)[CH:6]=[CH:7][C:8]=1[O:9][CH3:10].CC1C=CC(S(O[CH:32]2[CH2:37][CH2:36][N:35](C(OC(C)(C)C)=O)[CH2:34][CH2:33]2)(=O)=O)=CC=1>>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:11]2[C:12]([CH2:19][CH3:20])([CH2:17][CH3:18])[C:13](=[O:16])[N:14]([CH:32]3[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]3)[N:15]=2)[CH:6]=[CH:7][C:8]=1[O:9][CH3:10]

参加物

3

反応物 2

HCID 157347131-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine2 回HCID 666166225-(3,4-dimethoxyphenyl)-4,4-diethyl-2,4-dihydro-3H-pyrazol-3-one2 回

生成物 1

HCID 66616474HCID 66616474、化合物

実験手順

Prepared analogously as described for the example B1 (Alternative 1) using 5-(3,4-dimethoxyphenyl)-4,4-diethyl-2,4-dihydro-3H-pyrazol-3-one (compound C7) and tert-butyl 4-(Toluene-4-sulfonyloxy)piperidine-1-carboxylate (compound E1) as starting compounds resulting in the title compound. (compound B7)

後処理

  1. customPrepared analogously

出典と根拠

ORDレコード
ord-a7bfe601f7184030a696ae6109da24a0
出典データセット
uspto-grants-2013_12
特許番号
US08609848B2

関連ノート

読み込み中…